Epigenetic Drugs for Multiple Sclerosis

There is increasing evidence that abnormalities in epigenetic mechanisms of gene expression contribute to the development of multiple sclerosis (MS). Advances in epigenetics have given rise to a new class of drugs, epigenetic drugs. Although many classes of epigenetic drugs are being investigated, a...

Descripción completa

Detalles Bibliográficos
Autor principal: Peedicayil, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4787283/
https://www.ncbi.nlm.nih.gov/pubmed/26813117
http://dx.doi.org/10.2174/1570159X13666150211001600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4787283/
https://www.ncbi.nlm.nih.gov/pubmed/26813117
http://dx.doi.org/10.2174/1570159X13666150211001600

Ejemplares similares